Warangkana Munsakul

发表

Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial.

K. Ruxrungtham, D. Cooper, P. Phanuphak, 2016, The lancet. HIV.

A Prospective Study of Efficacy and Safety of Once-Daily Saquinavir/Ritonavir plus Two Nucleoside Reverse Transcriptase Inhibitors in Treatment-Naive Thai Patients

B. Hirschel, J. Ananworanich, R. Nuesch, 2005, Antiviral therapy.

Therapeutic effectiveness of a generic versus original meropenem in serious infections.

K. Jutivorakool, T. Tangkosakul, Nontakan Nuntachit, 2011, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial

Matthias Cavassini, Urs Karrer, Hansjakob Furrer, 2006, The Lancet.

A Randomized Comparison of Second-Line Lopinavir/ Ritonavir Monotherapy versus Tenofovir/Lamivudine/ Lopinavir/Ritonavir in Patients Failing Nnrti Regimens: The HIV Star Study

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2012, Antiviral therapy.

Long-Term Efficacy and Safety of First-Line Therapy with Once-Daily Saquinavir/Ritonavir

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2007, Antiviral therapy.

Dual contraceptive method use and pregnancy intention among people living with HIV receiving HIV care at six hospitals in Thailand

S. Pattanasin, Michael Martin, R. Lolekha, 2015, Reproductive Health.

The Impact of Combination Antiretroviral Therapy and its Interruption on Anxiety, Stress, Depression and Quality of Life in Thai Patients

B. Hirschel, K. Ruxrungtham, A. Gayet-Ageron, 2009, The open AIDS journal.

Implementation and assessment of a prevention with positives intervention among people living with HIV at five hospitals in Thailand

S. Pattanasin, Michael Martin, R. Lolekha, 2017, PloS one.

Absence of Resistance Mutations in Antiretroviral-Naive Patients Treated with Ritonavir-Boosted Saquinavir

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2005, Antiviral therapy.

HIV-1 Genital Shedding in HIV-Infected Patients Randomized to Second-Line Lopinavir/Ritonavir Monotherapy versus Tenofovir/Lamivudine/Lopinavir/ Ritonavir

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2014, Antiviral therapy.

Neurocognitive impairment in patients randomized to second-line lopinavir/ritonavir-based antiretroviral therapy vs. lopinavir/ritonavir monotherapy

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2012, Journal of NeuroVirology.

Supersensitive Viral Load Assay in Predicting CD4-Guided Treatment Failure

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2008, The open virology journal.

Etravirine and Rilpivirine Resistance in HIV-1 Subtype Crf01_Ae-Infected Adults Failing Non-Nucleoside Reverse Transcriptase Inhibitor-Based Regimens

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2011, Antiviral therapy.

A Randomized Comparison of Second-Line Lopinavir/ Ritonavir Monotherapy versus Tenofovir/Lamivudine/ Lopinavir/Ritonavir in Patients Failing Nnrti Regimens: The HIV Star Study

B. Hirschel, J. Ananworanich, K. Ruxrungtham, 2012 .